Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$30.19 - $39.11 $6.26 Million - $8.11 Million
-207,413 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$25.83 - $45.71 $170,219 - $301,228
6,590 Added 3.28%
207,413 $6.77 Million
Q4 2019

Feb 18, 2020

BUY
$37.87 - $45.37 $7.61 Million - $9.11 Million
200,823 New
200,823 $9.08 Million
Q3 2019

Nov 14, 2019

SELL
$40.31 - $43.45 $41.8 Million - $45.1 Million
-1,037,147 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$34.91 - $42.98 $34.1 Million - $42 Million
-976,502 Reduced 48.49%
1,037,147 $44.6 Million
Q1 2019

May 15, 2019

BUY
$32.91 - $40.75 $31.6 Million - $39.1 Million
960,109 Added 91.13%
2,013,649 $77.3 Million
Q4 2018

Feb 14, 2019

SELL
$31.73 - $39.04 $4.39 Million - $5.41 Million
-138,485 Reduced 11.62%
1,053,540 $37.2 Million
Q3 2018

Nov 14, 2018

BUY
$32.83 - $38.63 $39.1 Million - $46 Million
1,192,025 New
1,192,025 $45.9 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Capital International Investors Portfolio

Follow Capital International Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.